Page last updated: 2024-09-04

moxifloxacin and CACH Syndrome

moxifloxacin has been researched along with CACH Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baud, O; Bidet, P; Bingen, E; Biran, V; Bonacorsi, S; Brunel-Meunier, N; Charriaut-Marlangue, C; Gressens, P; Kitzis, MD; Le Saché, N; Pansiot, J; Pham, H	1

Other Studies

1 other study(ies) available for moxifloxacin and CACH Syndrome

Article	Year
Effect of moxifloxacin combined with cefotaxime compared to cefotaxime-gentamicin combination on prevention of white matter damage associated with Escherichia coli sepsis in neonatal rats. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:7 Topics: Animals; Animals, Newborn; Anti-Bacterial Agents; Aza Compounds; Cefotaxime; Escherichia coli Infections; Fluoroquinolones; Gentamicins; Leukoencephalopathies; Moxifloxacin; Quinolines; Rats; Rats, Sprague-Dawley; Sepsis	2011

Article

Year

Effect of moxifloxacin combined with cefotaxime compared to cefotaxime-gentamicin combination on prevention of white matter damage associated with Escherichia coli sepsis in neonatal rats.

Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:7

Topics: Animals; Animals, Newborn; Anti-Bacterial Agents; Aza Compounds; Cefotaxime; Escherichia coli Infections; Fluoroquinolones; Gentamicins; Leukoencephalopathies; Moxifloxacin; Quinolines; Rats; Rats, Sprague-Dawley; Sepsis

2011